1131870-40-0

Basic information

• Product Name: tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid methyl ester
• Synonyms: tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid methyl ester
• CAS NO: 1131870-40-0
• Molecular Weight: 516.638
• Mol File: 1131870-40-0.mol

Chemical Properties

• CAS DataBase Reference: tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid methyl ester(1131870-40-0)
• EPA Substance Registry System: tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid methyl ester(1131870-40-0)

Safety Data

• Hazardous Substances Data: 1131870-40-0(Hazardous Substances Data)

Upstream product

• 1046816-44-7 3-(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)propyl methanesulfonate 
• 225517-15-7 (S)-N^α-(tert-butyloxycarbonyl)-4-hydroxyphenylglycine methyl ester 

Downstream Products

• 1131870-42-2 tert-butoxycarbonylamino-(4-{3-[1-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]propoxy}phenyl)acetic acid 

Relevant articles and documents

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes.